To better understand the impact of the COVID‐19 pandemic on the care of patients with
pulmonary hypertension, we conducted a retrospective cohort study evaluating health …

Background: The coronavirus of 2019 (COVID-19) disrupted delivery of healthcare. Patients
with pulmonary hypertension (PH), especially pulmonary arterial hypertension (PAH) …

Regular expert follow‐up, risk assessment, and early therapeutic intervention minimize
worsening of pulmonary arterial hypertension (PAH). COVID‐19 lockdown measures were …

Rationale: Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic
pulmonary hypertension (CTEPH) typically undergo frequent clinical evaluation. The …

Abstract The coronavirus of 2019 (COVID-19) disrupted delivery of healthcare. Patients with
pulmonary hypertension (PH), especially pulmonary arterial hypertension (PAH), require …

The COVID-19 pandemic now impacts over 1.2 million individuals worldwide with higher risk
comorbidities including age, cardiac and pulmonary diseases. Pulmonary hypertension (PH) …

Information on outcomes of COVID-19 in pulmonary arterial hypertension (PAH) patients is
limited to a few case series and surveys. Here, we describe our experience at a large …

Pulmonary hypertension is frequently underdiagnosed, and referral is delayed with
subsequent impact on outcomes. During the SARS-CoV-2 pandemic, restrictions on daily …

Background and Objectives. COVID-19 infection has a significant burden on global
morbidity and mortality, especially in elderly people and in patients with chronic respiratory …

Abstract Coronavirus Disease 2019 (COVID-19) has been linked to severe consequences
among hospitalized patients diagnosed with pulmonary hypertension (PH), as evidenced by …